| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | RXST Rxsight, Inc. | Thunen Shelley B74 | Chief Financial Officer | Sell | 10,000 | $56.37 | $563,725.65 | -16.0% | +6.9% | -49.1% | |
| Mar 1, 2024 | Huller Kelly58 | SVP, GC, Corporate Secretary | Sell | 7,500 | $54.10 | $405,730.10 | -70.7% | +22.3% | +47.5% | ||
| Mar 1, 2024 | RMD Resmed Inc | Rider Michael J49 | Global General Counsel | Sell | 200 | $173.25 | $34,650.00 | -2.9% | +19.9% | +33.7% | |
| Mar 1, 2024 | NXGL Nexgel, Inc. | Drapczuk Adam E III62 | Chief Financial Officer | Buy | 47,394 | $2.11 | $100,001.34 | New | -14.7% | +28.4% | |
| Mar 1, 2024 | LUNG Pulmonx Corp | McKune John | Interim CFO | Sell | 1,078 | $9.06 | $9,766.68 | -0.7% | -21.5% | -7.3% | |
| Mar 1, 2024 | TMDX Transmedics Group, Inc. | Tobin James R60 | Director | Sell | 13,380 | $83.63 | $1,118,954.54 | -1.2% | +64.9% | -7.7% | |
| Mar 1, 2024 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $237.68 | $142,606.78 | -0.1% | -20.6% | +20.6% | |
| Mar 1, 2024 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 3,097 | $9.06 | $28,058.82 | -0.4% | -21.5% | -7.3% | |
| Mar 1, 2024 | ABT Abbott Laboratories | Moreland Mary K56 | Executive Vice President | Sell | 676 | $118.50 | $80,106.00 | -0.7% | -14.2% | +16.3% | |
| Mar 1, 2024 | ABT Abbott Laboratories | Salvadori Daniel Gesua Sive64 | Executive Vice President | Sell | 963 | $118.50 | $114,115.50 | -0.8% | -14.2% | +16.3% | |
| Mar 1, 2024 | ABT Abbott Laboratories | Morrone Louis H.70 | Executive Vice President | Sell | 801 | $118.50 | $94,918.50 | -1.3% | -14.2% | +16.3% | |
| Mar 1, 2024 | ABT Abbott Laboratories | Earnhardt Lisa D61 | Executive Vice President | Sell | 694 | $118.50 | $82,239.00 | -0.8% | -14.2% | +16.3% | |
| Mar 1, 2024 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 1,584 | $3.15 | $4,989.60 | -0.5% | +14.6% | -76.4% | |
| Mar 1, 2024 | ABT Abbott Laboratories | Allen Hubert L53 | Executive Vice President | Sell | 853 | $118.50 | $101,080.50 | -0.5% | -14.2% | +16.3% | |
| Mar 1, 2024 | ABT Abbott Laboratories | McCoy John A. Jr.45 | Vice President | Sell | 472 | $118.50 | $55,932.00 | -2.5% | -14.2% | +16.3% | |
| Feb 29, 2024 | EW Edwards Lifesciences Corp | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 7,255 | $85.59 | $620,922.80 | -27.6% | +2.5% | -15.6% | |
| Feb 29, 2024 | GKOS Glaukos Corp | Stapley Marc60 | Director | Sell | 6,250 | $90.09 | $563,086.85 | -5.7% | +24.6% | +35.5% | |
| Feb 29, 2024 | AVTR Avantor, Inc. | Bramwell James70 | EVP Sales, Customer Excellence | Sell | 4,910 | $24.52 | $120,393.20 | -4.9% | -4.3% | -32.2% | |
| Feb 29, 2024 | LMAT Lemaitre Vascular Inc | Pellegrino Joseph P Jr45 | Chief Financial Officer | Sell | 36,967 | $69.76 | $2,579,002.13 | -35.4% | +12.3% | +31.2% | |
| Feb 29, 2024 | ICUI Icu Medical Inc/de | Smiths Group Plc | Former 10% Owner | Sell | 830,000 | $106.08 | $88,042,250.00 | -33.2% | -7.4% | +34.0% | |
| Feb 29, 2024 | ICUI Icu Medical Inc/de | Smiths Group International Holdings Ltd | Former 10% Owner | Sell | 830,000 | $106.08 | $88,042,250.00 | -33.2% | -7.4% | +34.0% | |
| Feb 29, 2024 | AVTR Avantor, Inc. | Couturier Christophe75 | EVP, Amea | Sell | 13,074 | $24.53 | $320,705.22 | -13.5% | -4.3% | -32.2% | |
| Feb 29, 2024 | INSP Inspire Medical Systems, Inc. | Rondoni John79 | Chief Technology Officer | Sell | 8,605 | $179.25 | $1,542,440.80 | -11.0% | -10.4% | +3.7% | |
| Feb 29, 2024 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, GC, CCO And Cs | Sell | 28,403 | $3.11 | $88,427.76 | -3.5% | -32.0% | +41.7% | |
| Feb 29, 2024 | IRTC Irhythm Holdings, Inc. | Murphy Patrick Michael55 | Cbo And CLO | Sell | 7,615 | $121.96 | $928,725.40 | -13.5% | -26.9% | -7.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.